JP2003277220A - External preparation for skin - Google Patents
External preparation for skinInfo
- Publication number
- JP2003277220A JP2003277220A JP2002085075A JP2002085075A JP2003277220A JP 2003277220 A JP2003277220 A JP 2003277220A JP 2002085075 A JP2002085075 A JP 2002085075A JP 2002085075 A JP2002085075 A JP 2002085075A JP 2003277220 A JP2003277220 A JP 2003277220A
- Authority
- JP
- Japan
- Prior art keywords
- external preparation
- skin
- fatty acid
- acid
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 34
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 34
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 27
- 239000000194 fatty acid Substances 0.000 claims abstract description 27
- 229930195729 fatty acid Natural products 0.000 claims abstract description 27
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 19
- 239000002253 acid Substances 0.000 claims abstract description 15
- 150000002148 esters Chemical class 0.000 claims abstract description 13
- 239000007788 liquid Substances 0.000 claims abstract description 12
- 108010028921 Lipopeptides Proteins 0.000 claims abstract description 8
- 239000000839 emulsion Substances 0.000 claims description 23
- 235000011187 glycerol Nutrition 0.000 claims description 14
- 244000005700 microbiome Species 0.000 claims description 6
- 230000000813 microbial effect Effects 0.000 abstract description 2
- -1 alkali metal salts Chemical class 0.000 description 18
- 239000000203 mixture Substances 0.000 description 10
- 238000003860 storage Methods 0.000 description 10
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 8
- 239000006071 cream Substances 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
- 230000003796 beauty Effects 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 4
- AFWTZXXDGQBIKW-UHFFFAOYSA-N C14 surfactin Natural products CCCCCCCCCCCC1CC(=O)NC(CCC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O1 AFWTZXXDGQBIKW-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- 239000004359 castor oil Substances 0.000 description 4
- 235000019438 castor oil Nutrition 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 4
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- NJGWOFRZMQRKHT-UHFFFAOYSA-N surfactin Natural products CC(C)CCCCCCCCCC1CC(=O)NC(CCC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O1 NJGWOFRZMQRKHT-UHFFFAOYSA-N 0.000 description 4
- NJGWOFRZMQRKHT-WGVNQGGSSA-N surfactin C Chemical compound CC(C)CCCCCCCCC[C@@H]1CC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O1 NJGWOFRZMQRKHT-WGVNQGGSSA-N 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 3
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 3
- 240000000912 Macadamia tetraphylla Species 0.000 description 3
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000686 essence Substances 0.000 description 3
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- 239000010466 nut oil Substances 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 2
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 2
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 2
- 244000144730 Amygdalus persica Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- PSFABYLDRXJYID-VKHMYHEASA-N N-Methylserine Chemical compound CN[C@@H](CO)C(O)=O PSFABYLDRXJYID-VKHMYHEASA-N 0.000 description 2
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 235000006040 Prunus persica var persica Nutrition 0.000 description 2
- 108010077895 Sarcosine Proteins 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 229960000735 docosanol Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 229950006780 n-acetylglucosamine Drugs 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 229940073665 octyldodecyl myristate Drugs 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- JYVXNLLUYHCIIH-UHFFFAOYSA-N (+/-)-mevalonolactone Natural products CC1(O)CCOC(=O)C1 JYVXNLLUYHCIIH-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- JSPNNZKWADNWHI-PNANGNLXSA-N (2r)-2-hydroxy-n-[(2s,3r,4e,8e)-3-hydroxy-9-methyl-1-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadeca-4,8-dien-2-yl]heptadecanamide Chemical compound CCCCCCCCCCCCCCC[C@@H](O)C(=O)N[C@H]([C@H](O)\C=C\CC\C=C(/C)CCCCCCCCC)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JSPNNZKWADNWHI-PNANGNLXSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- YICVJSOYNBZJAK-UHFFFAOYSA-N 14-methylpentadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C YICVJSOYNBZJAK-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 1
- FUWVMBCPMRAWPG-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-hydroxyoctadecanoate Chemical compound CCCCCCCCCCCCCCCCC(O)C(=O)OCC(O)CO FUWVMBCPMRAWPG-UHFFFAOYSA-N 0.000 description 1
- QXKAEQCGFVTAMN-UHFFFAOYSA-N 2-(2-hydroxy-3-methoxy-5-methylphenyl)-6-methoxy-4-methylphenol Chemical compound COC1=CC(C)=CC(C=2C(=C(OC)C=C(C)C=2)O)=C1O QXKAEQCGFVTAMN-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- HECDBQWSOGTQMT-UHFFFAOYSA-N 2-(hydroxyamino)butanoic acid Chemical compound CCC(NO)C(O)=O HECDBQWSOGTQMT-UHFFFAOYSA-N 0.000 description 1
- PMUNIMVZCACZBB-UHFFFAOYSA-N 2-hydroxyethylazanium;chloride Chemical compound Cl.NCCO PMUNIMVZCACZBB-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- TVIMZSOUQXNWHO-UHFFFAOYSA-N 2-tetradecanoylglycerol Chemical compound CCCCCCCCCCCCCC(=O)OC(CO)CO TVIMZSOUQXNWHO-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- HXMCERBOSXQYRH-KSVGBCIHSA-N Arthrofactin Chemical compound CCCCCCCC1CC(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H]([C@H](C)O)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(=O)O1 HXMCERBOSXQYRH-KSVGBCIHSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 239000004381 Choline salt Substances 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 244000008991 Curcuma longa Species 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- ILKBHIBYKSHTKQ-UHFFFAOYSA-N Diisopropylamine dichloroacetate Chemical compound OC(=O)C(Cl)Cl.CC(C)NC(C)C ILKBHIBYKSHTKQ-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- INJOMKTZOLKMBF-UHFFFAOYSA-N Guanfacine Chemical compound NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl INJOMKTZOLKMBF-UHFFFAOYSA-N 0.000 description 1
- 240000008669 Hedera helix Species 0.000 description 1
- 235000013537 Helichrysum petiolatum Nutrition 0.000 description 1
- 244000308760 Helichrysum petiolatum Species 0.000 description 1
- 235000005206 Hibiscus Nutrition 0.000 description 1
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical class NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- DUKURNFHYQXCJG-UHFFFAOYSA-N Lewis A pentasaccharide Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(C)=O)C(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)OC1CO DUKURNFHYQXCJG-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- PSFABYLDRXJYID-UHFFFAOYSA-N N-methyl-DL-serine Natural products CNC(CO)C(O)=O PSFABYLDRXJYID-UHFFFAOYSA-N 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 244000141353 Prunus domestica Species 0.000 description 1
- JYVXNLLUYHCIIH-ZCFIWIBFSA-N R-mevalonolactone, (-)- Chemical compound C[C@@]1(O)CCOC(=O)C1 JYVXNLLUYHCIIH-ZCFIWIBFSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 241001125046 Sardina pilchardus Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 239000004115 Sodium Silicate Substances 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical class CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- YRXGUZPUZBCGST-UHFFFAOYSA-N [2-(hydroxymethoxy)phenyl]-phenylmethanone Chemical compound OCOC1=CC=CC=C1C(=O)C1=CC=CC=C1 YRXGUZPUZBCGST-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940124277 aminobutyric acid Drugs 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 150000001483 arginine derivatives Chemical class 0.000 description 1
- 229960003589 arginine hydrochloride Drugs 0.000 description 1
- 108010066374 arthrofactin Proteins 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 125000003178 carboxy group Chemical class [H]OC(*)=O 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000007765 cera alba Substances 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229930183167 cerebroside Natural products 0.000 description 1
- RIZIAUKTHDLMQX-UHFFFAOYSA-N cerebroside D Natural products CCCCCCCCCCCCCCCCC(O)C(=O)NC(C(O)C=CCCC=C(C)CCCCCCCCC)COC1OC(CO)C(O)C(O)C1O RIZIAUKTHDLMQX-UHFFFAOYSA-N 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 235000019417 choline salt Nutrition 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical class OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 1
- 229940043276 diisopropanolamine Drugs 0.000 description 1
- 229940084113 diisopropylamine dichloroacetate Drugs 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 229940073579 ethanolamine hydrochloride Drugs 0.000 description 1
- 150000002169 ethanolamines Chemical class 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229940074774 glycyrrhizinate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- SFFVATKALSIZGN-UHFFFAOYSA-N hexadecan-7-ol Chemical compound CCCCCCCCCC(O)CCCCCC SFFVATKALSIZGN-UHFFFAOYSA-N 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 150000001261 hydroxy acids Chemical class 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229940078568 isocetyl myristate Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000011147 magnesium chloride Nutrition 0.000 description 1
- NGPNWUWGVIIIDG-LEJBHHMKSA-L magnesium;[(2r)-2-[(1s)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2h-furan-3-yl] phosphate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1OP([O-])([O-])=O NGPNWUWGVIIIDG-LEJBHHMKSA-L 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- DEQXHPXOGUSHDX-UHFFFAOYSA-N methylaminomethanetriol;hydrochloride Chemical compound Cl.CNC(O)(O)O DEQXHPXOGUSHDX-UHFFFAOYSA-N 0.000 description 1
- 229940057061 mevalonolactone Drugs 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N monoethanolamine hydrochloride Natural products NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229940075999 phytosterol ester Drugs 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003248 quinolines Chemical class 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000011863 silicon-based powder Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229940080236 sodium cetyl sulfate Drugs 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- 229910052911 sodium silicate Inorganic materials 0.000 description 1
- 235000019794 sodium silicate Nutrition 0.000 description 1
- 229940074404 sodium succinate Drugs 0.000 description 1
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- WTWSHHITWMVLBX-DKWTVANSSA-M sodium;(2s)-2-aminobutanedioate;hydron Chemical compound [Na+].[O-]C(=O)[C@@H](N)CC(O)=O WTWSHHITWMVLBX-DKWTVANSSA-M 0.000 description 1
- GGHPAKFFUZUEKL-UHFFFAOYSA-M sodium;hexadecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCCCOS([O-])(=O)=O GGHPAKFFUZUEKL-UHFFFAOYSA-M 0.000 description 1
- QKHBMQWPOUUMQZ-BDQAORGHSA-M sodium;hydron;(2s)-2-(octadecanoylamino)pentanedioate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC([O-])=O QKHBMQWPOUUMQZ-BDQAORGHSA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 150000005621 tetraalkylammonium salts Chemical class 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical class CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical class CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は皮膚外用剤に関す
る。更に詳しくは、グリセリンモノ脂肪酸エステルを多
量に含有しながら幅広い粘度領域を持ち、且つ保存安定
性に優れた乳化型皮膚外用剤に関する。TECHNICAL FIELD The present invention relates to an external preparation for skin. More specifically, it relates to an emulsion type external preparation for external use which has a wide viscosity range while containing a large amount of glycerin monofatty acid ester and is excellent in storage stability.
【0002】[0002]
【従来の技術】グリセリンモノ脂肪酸エステルは皮膚外
用剤の汎用原料であり、親油型界面活性剤としてローシ
ョン、乳液、ジェル、クリーム、クレンジング料等に多
く用いられている。BACKGROUND OF THE INVENTION Glycerin monofatty acid ester is a general-purpose raw material for external preparations for skin, and is widely used as a lipophilic surfactant in lotions, emulsions, gels, creams, cleansing agents and the like.
【0003】[0003]
【発明が解決しようとする問題点】しかしながら、グリ
セリンモノ脂肪酸エステルは製剤中で結晶化することが
多く、且つ多量に製剤中に配合した場合、粘度を著しく
上昇させる。ゆえに、強く望まれているにもかかわら
ず、グリセリンモノ脂肪酸エステルを多量に配合しなが
ら、幅広い粘度領域(乳液状〜クリーム状〜固形状)の
製剤を調製すること、そして優れた保存安定性を得るこ
とは非常に困難であった。However, glycerin monofatty acid ester often crystallizes in the preparation, and when it is incorporated in a large amount in the preparation, the viscosity is remarkably increased. Therefore, despite being strongly desired, while preparing a large amount of glycerin monofatty acid ester, it is possible to prepare a formulation in a wide viscosity range (milky liquid to creamy to solid) and to have excellent storage stability. It was very difficult to get.
【0004】[0004]
【発明が解決しようとする課題】かかる事情に鑑み、本
発明は、グリセリンモノ脂肪酸エステルを多量に含有し
ながら幅広い粘度領域を持ち、且つ保存安定性に優れた
乳化型皮膚外用剤を提供することを目的とする。In view of such circumstances, the present invention provides an emulsion type external preparation for skin which has a wide viscosity range while containing a large amount of glycerin monofatty acid ester and is excellent in storage stability. With the goal.
【0005】[0005]
【課題を解決するための手段】本発明者等は、種々検討
の結果、グリセリンモノ脂肪酸エステルを含有する乳化
型皮膚外用剤において、微生物由来のリポペプチド類及
び25℃で液状の高級脂肪酸を配合することにより、上
記目的が達成されることを見出し、本発明を完成した。Means for Solving the Problems As a result of various studies, the present inventors have found that in an emulsion type external preparation for skin containing glycerin monofatty acid ester, lipopeptides derived from a microorganism and higher fatty acid liquid at 25 ° C. are mixed. By doing so, they have found that the above-mentioned object can be achieved, and completed the present invention.
【0006】すなわち本発明の請求項1は、(A)グリ
セリンモノ脂肪酸エステル、(B)微生物由来のリポペ
プチド類、及び(C)25℃で液状の高級脂肪酸を含有
することを特徴とする乳化型皮膚外用剤である。That is, claim 1 of the present invention comprises (A) a glycerin monofatty acid ester, (B) a lipopeptide derived from a microorganism, and (C) an emulsified liquid fatty acid at 25 ° C. Type external preparation for skin.
【0007】また本発明の請求項2は、(C)25℃で
液状の高級脂肪酸が分岐脂肪酸であることを特徴とする
請求項1記載の乳化型皮膚外用剤である。A second aspect of the present invention is the emulsion type external preparation for skin according to the first aspect, characterized in that (C) the higher fatty acid liquid at 25 ° C. is a branched fatty acid.
【0008】[0008]
【発明の実施の形態】以下、本発明の構成について詳説
する。BEST MODE FOR CARRYING OUT THE INVENTION The structure of the present invention will be described in detail below.
【0009】本発明で用いられる(A)グリセリンモノ
脂肪酸エステルは、化粧品原料として公知の物質であ
り、具体例としてはモノステアリン酸グリセリン、モノ
イソステアリン酸グリセリン、モノオレイン酸グリセリ
ン、モノヒドロキシステアリン酸グリセリン、モノミリ
スチン酸グリセリン等が挙げられ、これらを1種単独又
は2種以上を組み合わせて用いることができる。The glycerin monofatty acid ester (A) used in the present invention is a substance known as a raw material for cosmetics, and specific examples thereof include glyceryl monostearate, glyceryl monoisostearate, glyceryl monooleate, and glyceryl monohydroxystearate. , Glycerin monomyristate, etc., and these can be used alone or in combination of two or more.
【0010】本発明に用いられる(A)グリセリンモノ
脂肪酸エステルの配合量は、乳化型皮膚外用剤の総量を
基準として、2〜28質量%(以下、単に%と略す)が
好ましく、特に好ましくは4〜16%である。配合量が
2〜28%の範囲外では、安定な皮膚外用剤を得ること
ができない場合がある。The amount of glycerin monofatty acid ester (A) used in the present invention is preferably 2 to 28% by mass (hereinafter simply abbreviated as%), and particularly preferably, based on the total amount of the emulsion type external preparation for skin. It is 4 to 16%. If the blending amount is outside the range of 2 to 28%, a stable external preparation for skin may not be obtained in some cases.
【0011】本発明で用いられる(B)微生物由来のリ
ポペプチド類は、化粧品原料として公知の物質であり、
特開2000−327591号公報に記載されているよ
うな、バチルス属微生物等原核生物に由来したリポペプ
チド化合物を使用することが好ましい。微生物由来のリ
ポペプチド類としては、例えば、サーファクチン[Bioc
hem.Bioph.Res.Commun.,31:488-494,(1968)]、プリパ
スタチン[J.Antibiot.,Vol.39,No.6,745-761,(198
6)]、アースロファクチン[J.Bacteriol.,Vol.175,No.
20,6459-6466,(1993)]、イチュリン[Biochemistry,Vo
l.17,No.19,3992-3996,(1978)]セラウェッチン[J.Bac
teriol.,Vol.174,No.6,1769-1772,(1992)]、及びそれ
らの構成単位であるアミノ酸由来のカルボキシル基の金
属塩(ナトリウム、カリウム、リチウム等のアルカリ金
属塩、カルシウム、マグネシウム等のアルカリ土類金属
塩等)や有機アンモニウム塩(トリメチルアミン塩、ト
リエチルアミン塩、トリブチルアミン塩、モノエタノー
ルアミン塩、ジエタノールアミン塩、トリエタノールア
ミン塩、リジン塩、アルギニン塩、コリン塩等)等が挙
げられ、サーファクチンナトリウム(商品名:アミノフ
ェクト、昭和電工社製)を使用することが特に好まし
い。The (B) microbial-derived lipopeptides used in the present invention are known substances as cosmetic raw materials,
It is preferable to use a lipopeptide compound derived from a prokaryote such as a microorganism of the genus Bacillus as described in JP-A-2000-327591. Examples of lipopeptides derived from microorganisms include surfactin [Bioc
hem.Bioph.Res.Commun., 31: 488-494, (1968)], Pripastatin [J. Antibiot., Vol. 39, No. 6, 745-761, (198
6)], Arthrofactin [J. Bacteriol., Vol.175, No.
20,6459-6466, (1993)], Iturin [Biochemistry, Vo
l.17, No.19,3992-3996, (1978)] Serawechin [J.Bac
teriol., Vol.174, No.6, 1769-1772, (1992)], and metal salts of carboxyl groups derived from amino acids which are their constituent units (alkali metal salts such as sodium, potassium and lithium, calcium, magnesium) Alkaline earth metal salts such as) and organic ammonium salts (trimethylamine salt, triethylamine salt, tributylamine salt, monoethanolamine salt, diethanolamine salt, triethanolamine salt, lysine salt, arginine salt, choline salt, etc.) and the like. It is particularly preferable to use surfactin sodium (trade name: Aminofect, manufactured by Showa Denko KK).
【0012】本発明で用いられる(B)微生物由来のリ
ポペプチド類の配合量は、乳化型皮膚外用剤の総量を基
準として、0.05〜9%が好ましく、特に好ましくは
0.1〜5%である。配合量が0.05%未満では、本
発明の目的を達成することができない場合があり、また
9%を超えて配合しても、その超えた配合量に見合った
効果の増大が得られない場合がある。The amount of the (B) microorganism-derived lipopeptides used in the present invention is preferably 0.05 to 9%, particularly preferably 0.1 to 5%, based on the total amount of the emulsion type external preparation for skin. %. If the blending amount is less than 0.05%, the object of the present invention may not be achieved, and if the blending amount exceeds 9%, an increase in the effect commensurate with the exceeding blending amount cannot be obtained. There are cases.
【0013】本発明で用いられる高級脂肪酸は、化粧品
原料として公知の物質であり、25℃で液状であればよ
く、例えば不飽和脂肪酸、分岐脂肪酸等が挙げられる。
不飽和脂肪酸としては、例えばオレイン酸、パルミトレ
イン酸、リノール酸、リノレン酸等が挙げられ、分岐脂
肪酸としては、例えば大豆油、綿実油等の植物油、又は
硬化油から抽出した分岐脂肪酸や、植物油を原料とする
ダイマー酸の製造時における副産物として生成する分岐
脂肪酸が挙げられる。特に臭い等の嗜好性面から飽和分
岐脂肪酸が望ましく、特に望ましくはイソステアリン酸
である。The higher fatty acid used in the present invention is a substance known as a raw material for cosmetics and may be liquid at 25 ° C., and examples thereof include unsaturated fatty acids and branched fatty acids.
Examples of unsaturated fatty acids include oleic acid, palmitoleic acid, linoleic acid, and linolenic acid. Examples of branched fatty acids include soybean oil, vegetable oils such as cottonseed oil, or branched fatty acids extracted from hydrogenated oil, and vegetable oils as raw materials. The branched fatty acid produced as a by-product during the production of dimer acid In particular, saturated branched fatty acids are desirable from the aspect of taste and the like, and isostearic acid is particularly desirable.
【0014】本発明で用いられる(C)25℃で液状の
高級脂肪酸の配合量は、乳化型皮膚外用剤の総量を基準
として、0.01〜60%が好ましく、特に好ましくは
0.05〜40%である。配合量が0.01%未満で
は、本発明の目的を達成することができない場合があ
り、また60%を超えて配合しても、その超えた配合量
に見合った効果の増大が得られない場合がある。The amount of the higher fatty acid (C) liquid at 25 ° C. used in the present invention is preferably 0.01 to 60%, and particularly preferably 0.05 to 60%, based on the total amount of the emulsion type external preparation for skin. 40%. If the blending amount is less than 0.01%, the object of the present invention may not be achieved, and if the blending amount exceeds 60%, the effect commensurate with the exceeding blending amount cannot be obtained. There are cases.
【0015】尚、本発明の乳化型皮膚外用剤には上記の
必須成分の他に、本発明の目的を達成する範囲で他の成
分、例えば、デカメチルシクロペンタシロキサン、オク
タメチルシクロテトラシロキサン、メチルフェニルポリ
シロキサン、ジメチルポリシロキサン等のシリコーン
油、パラフィン、ワセリン等の炭化水素類、オリーブス
クワラン、米スクワラン、米糠油、オリーブ油、大豆
油、米胚芽油、ホホバ油、ヒマシ油、紅花油、ヒマワリ
油、マカデミアナッツ油等の植物油、ミツロウ、モクロ
ウ、カルナウバロウ等のロウ類、ミリスチン酸オクチル
ドデシル、パルミチン酸セチル等のエステル油、セタノ
ール、ベヘニルアルコール、ステアリルアルコール、イ
ソステアリルアルコール等の高級アルコール類、コレス
テロール、フィトステロール等のステロール類、分岐脂
肪酸コレステロールエステル、マカデミアナッツ油脂肪
酸フィトステロールエステル等のステロール脂肪酸エス
テル類、セチル硫酸ナトリウム、N−ステアロイル−L
−グルタミン酸塩等の陰イオン界面活性剤、ポリオキシ
エチレンアルキルエーテル、ポリオキシエチレン脂肪酸
エステル、ポリオキシエチレン多価アルコール脂肪酸エ
ステル、ポリオキシエチレン硬化ヒマシ油、多価アルコ
ール脂肪酸エステル、ポリグリセリン脂肪酸エステル、
蔗糖脂肪酸エステル等の非イオン界面活性剤、テトラア
ルキルアンモニウム塩等の陽イオン界面活性剤、ベタイ
ン型、スルホベタイン型、スルホアミノ酸型等の両性界
面活性剤、レシチン、水素添加レシチン、リゾフォスフ
ァチジルコリン、セラミド、セレブロシド等の天然系界
面活性剤、ポリエーテル変性シリコーン、アミノ変性シ
リコーン等のシリコーン系界面活性剤、硬化油等の加工
油類、トリイソステアリン酸グリセリル、トリ(カプリ
ル・カプリン酸)グリセリル、トリ2−エチルヘキサン
酸グリセリル等のトリグリセリド、タール系色素、酸化
鉄等の着色顔料、パラベン、フェノキシエタノール等の
防腐剤、酸化チタン、酸化亜鉛等の顔料、ジブチルヒド
ロキシトルエン、デヒドロジクレオソール等の抗酸化
剤、エタノール等の一級アルコール、塩化ナトリウム、
塩化マグネシウム、硫酸ナトリウム、硝酸カリウム、珪
酸ナトリウム等の無機塩類、琥珀酸ナトリウム、アスパ
ラギン酸ナトリウム等の有機酸塩類、塩酸エタノールア
ミン、硝酸アンモニウム、塩酸アルギニン、燐酸塩、ク
エン酸塩、酢酸塩、炭酸塩、トリスヒドロキシメチルア
ミノメタン塩酸塩、ジイソプロピルアミンジクロロ酢酸
塩等の塩類、カルボキシビニルポリマー、キサンタンガ
ム、カラギーナン、ペクチン、アルキル変性カルボキシ
ビニルポリマー等の増粘剤、エデト酸等のキレート剤、
水酸化カリウム、ジイソプロパノールアミン、トリエタ
ノールアミン等の中和剤、ジプロピレングリコール、
1,3−ブチレングリコール、グリセリン、プロピレン
グリコール、ソルビトール、マルチトール、ジグリセリ
ン、アセチルグルコサミン等の多価アルコール、乳酸等
のヒドロキシ酸、ヒアルロン酸、コラーゲン、シルク蛋
白等の生体高分子、乳酸菌、酵母等の培養生成物、カミ
ツレ、センブリ、アロエ、モモ、カロット、スギナ、ク
ワ、桃の葉、セージ、ビワ葉、キュウカンバー、セイヨ
ウキズタ、ハイビスカス、ウコン、ローズマリー、オウ
ゴン、チョウジ、フェンネル、プルーン、甘草等の植物
エキス、セリン、スレオニン、N−メチルグリシン、N
−メチル−l−セリン、アミノ酪酸、ヒドロキシアミノ
酪酸等のアミノ酸類、ヒドロキシメトキシベンゾフェノ
ンスルフォン酸塩等の紫外線吸収剤、ビタミンA類、B
類、C類、E類等のビタミン類、グリチルリチン酸塩、
香料等を用いることができるがこれに限定されるもので
はない。In the emulsion type external preparation for skin of the present invention, in addition to the above-mentioned essential components, other components such as decamethylcyclopentasiloxane, octamethylcyclotetrasiloxane, etc. within a range to achieve the object of the present invention, Silicone oils such as methylphenylpolysiloxane and dimethylpolysiloxane, hydrocarbons such as paraffin and vaseline, olive squalane, rice squalane, rice bran oil, olive oil, soybean oil, rice germ oil, jojoba oil, castor oil, safflower oil, sunflower Oils, vegetable oils such as macadamia nut oil, waxes such as beeswax, syrup and carnauba wax, octyldodecyl myristate, ester oils such as cetyl palmitate, higher alcohols such as cetanol, behenyl alcohol, stearyl alcohol and isostearyl alcohol, cholesterol, phytoste Sterols such Lumpur, branched fatty acid cholesterol esters, sterol fatty acid esters such as macadamia nut oil fatty acid phytosterol esters, sodium cetyl sulfate, N- stearoyl -L
Anionic surfactant such as glutamate, polyoxyethylene alkyl ether, polyoxyethylene fatty acid ester, polyoxyethylene polyhydric alcohol fatty acid ester, polyoxyethylene hydrogenated castor oil, polyhydric alcohol fatty acid ester, polyglycerin fatty acid ester,
Nonionic surfactants such as sucrose fatty acid ester, cationic surfactants such as tetraalkylammonium salt, amphoteric surfactants such as betaine type, sulfobetaine type and sulfoamino acid type, lecithin, hydrogenated lecithin, lysophosphatidyl Natural surfactants such as choline, ceramide, cerebroside, silicone-based surfactants such as polyether-modified silicone and amino-modified silicone, processed oils such as hardened oil, glyceryl triisostearate, glyceryl tri (capryl / capric acid) , Triglycerides such as glyceryl tri-2-ethylhexanoate, tar pigments, coloring pigments such as iron oxide, preservatives such as paraben and phenoxyethanol, pigments such as titanium oxide and zinc oxide, dibutylhydroxytoluene, dehydrodicresol and the like. Antioxidants, ethanol, etc. Grade alcohol, sodium chloride,
Inorganic salts such as magnesium chloride, sodium sulfate, potassium nitrate and sodium silicate, organic acid salts such as sodium succinate and sodium aspartate, ethanolamine hydrochloride, ammonium nitrate, arginine hydrochloride, phosphate, citrate, acetate, carbonate, Trishydroxymethylaminomethane hydrochloride, salts such as diisopropylamine dichloroacetate, carboxyvinyl polymer, xanthan gum, carrageenan, pectin, thickeners such as alkyl modified carboxyvinyl polymer, chelating agents such as edetic acid,
Neutralizer such as potassium hydroxide, diisopropanolamine, triethanolamine, dipropylene glycol,
Polyhydric alcohols such as 1,3-butylene glycol, glycerin, propylene glycol, sorbitol, maltitol, diglycerin and acetylglucosamine, hydroxy acids such as lactic acid, biopolymers such as hyaluronic acid, collagen and silk protein, lactic acid bacteria, yeast Culture products such as chamomile, assembly, aloe, peach, carrot, horsetail, mulberry, peach leaf, sage, loquat leaf, cucumber, Ivy, hibiscus, turmeric, rosemary, sardine, clove, fennel, prune, Licorice plant extract, serine, threonine, N-methylglycine, N
-Amino acids such as methyl-l-serine, aminobutyric acid and hydroxyaminobutyric acid, ultraviolet absorbers such as hydroxymethoxybenzophenone sulfonate, vitamins A and B
, Vitamins such as Cs, Es, glycyrrhizinate,
Fragrances and the like can be used, but are not limited thereto.
【0016】本発明の乳化型皮膚外用剤は、常法に従っ
て製造することができ、前記必須成分及び任意成分の配
合量を適宜選択して用いることにより、乳液状〜クリー
ム状〜固形状の幅広い粘度領域のものを容易に得ること
ができる。The emulsion type external preparation for skin of the present invention can be produced according to a conventional method, and by appropriately selecting the compounding amounts of the above-mentioned essential components and optional components and using them, a wide range of emulsions to creams to solids can be obtained. The viscosity range can be easily obtained.
【0017】また本発明の乳化型皮膚外用剤は、化粧
料、医薬部外品、医薬品等に適用することができ、その
使用形態としては、例えば美溶液、ローション、乳液、
パック、化粧下地、メイクアップ料、マッサージ料、ク
レンジング料等が挙げられる。Further, the emulsion type external preparation for skin of the present invention can be applied to cosmetics, quasi drugs, pharmaceuticals and the like, and its usage forms are, for example, beauty solution, lotion, emulsion,
Examples include packs, makeup bases, makeup charges, massage charges, cleansing charges and the like.
【0018】[0018]
【実施例】以下、実施例及び比較例により詳細に説明す
るが、本発明はこれら実施例に限定されるものではな
い。尚、組成の単位は全て質量%である。EXAMPLES The present invention will be described in detail below with reference to examples and comparative examples, but the present invention is not limited to these examples. In addition, all units of composition are mass%.
【0019】実施例に先立ち、本発明の皮膚外用剤、及
び比較例の皮膚外用剤を用いた保存安定性試験について
述べる。Prior to the examples, a storage stability test using the external preparation for skin of the present invention and the external preparation for skin of Comparative Example will be described.
【0020】<保存安定性試験>試料をガラスビンに入
れ、室温で3週間放置後の状態及び外観を観察し、異常
が認められる場合(分離、析出)を×で表し、異常が認
められない場合を○で表した。<Storage Stability Test> A sample was placed in a glass bottle, and the condition and appearance after standing at room temperature for 3 weeks were observed. If any abnormality was observed (separation or precipitation), it was represented by x, and no abnormality was observed. Is represented by a circle.
【0021】実施例1〜5、比較例1〜4(乳液)
表1記載の組成で下記の調製法に従い乳液を調製し、前
記の試験を実施した。結果を表1に併せて示す。Examples 1 to 5 and Comparative Examples 1 to 4 (Emulsion) An emulsion having the composition shown in Table 1 was prepared according to the following preparation method, and the above test was carried out. The results are also shown in Table 1.
【0022】(1)組成(1) Composition
【表1】 [Table 1]
【0023】(2)調製法
成分a及び成分bを各々80℃で溶解した後混合して、
攪拌しつつ冷却し、30℃まで冷却して、乳液を調製し
た。(2) Preparation Method Components a and b are each melted at 80 ° C. and then mixed,
The emulsion was prepared by cooling with stirring and cooling to 30 ° C.
【0024】(3)結果
表1より明らかなように本発明に係る乳液(実施例1〜
5)は比較例1〜4の乳液と比べて、優れた保存安定性
が認められた。(3) Results As is clear from Table 1, the emulsion according to the present invention (Examples 1 to 1)
In 5), excellent storage stability was recognized as compared with the emulsions of Comparative Examples 1 to 4.
【0025】実施例6、比較例5〜14(クリーム)
表2記載の組成で下記の調製法に従いクリームを調製
し、前記の試験を実施した。結果を表2に併せて示す。Example 6, Comparative Examples 5 to 14 (Cream) Creams having the compositions shown in Table 2 were prepared according to the following preparation method, and the above-mentioned tests were carried out. The results are also shown in Table 2.
【0026】(1)組成(1) Composition
【表2】 [Table 2]
【0027】(2)調製法
成分a及び成分bを各々80℃で溶解した後混合して、
攪拌しつつ冷却し、30℃まで冷却して、クリームを調
製した。(2) Preparation Method Components a and b are each melted at 80 ° C. and then mixed,
Cooled with stirring and cooled to 30 ° C. to prepare a cream.
【0028】(3)結果
表2より明らかなように本発明に係るクリーム(実施例
6)は、25℃で液状である他の油剤を配合した比較例
5〜14のクリームと比べて、優れた保存安定性が認め
られた。(3) Results As is clear from Table 2, the cream according to the present invention (Example 6) is superior to the creams of Comparative Examples 5 to 14 in which other oil agents which are liquid at 25 ° C. are blended. The storage stability was confirmed.
【0029】実施例7〜9(乳液)
下記の組成及び調製法に従い乳液を調製し、前記の試験
を実施した。Examples 7 to 9 (Emulsion) An emulsion was prepared according to the following composition and preparation method, and the above test was carried out.
【0030】 (1)組成 実施例7 実施例8 実施例9 成分a イソステアリン酸 1.0 1.0 3.0 モノステアリン酸グリセリン 4.0 4.0 4.0 ベヘニルアルコール 2.0 2.0 2.0 サラシミツロウ 1.0 1.0 − ミリスチン酸セチル 1.0 1.0 1.0 セスキオレイン酸ソルビタン 1.0 1.0 1.0 長鎖分岐脂肪酸コレステリル *1 0.1 0.1 0.1 水素添加レシチン 0.1 0.1 0.1 植物スクワラン 5.0 5.0 5.0 ミリスチン酸オクチルドデシル 5.0 5.0 5.0 成分b サーファクチンナトリウム 0.1 1.0 0.1 1,3−ブチレングリコール 5.0 10.0 0.5 ソルビトール液 5.0 5.0 5.0 ポリエチレングリコール4000 0.2 0.2 0.2 カルボキシビニルポリマー 0.1 0.1 0.1 パラオキシ安息香酸メチル 0.2 0.2 0.2 メバロノラクトン 0.1 0.1 0.1 エデト酸二ナトリウム 0.2 0.2 0.2 ラズベリーケトングルコシド 0.05 0.05 0.05 塩化ナトリウム 0.1 0.1 0.1 ジプロピレングリコール 0.1 0.1 0.1 濃グリセリン 5.0 5.0 5.0 ラフィノース 0.1 0.1 0.1 アスコルビン酸2−グルコシド 0.1 0.1 0.1 カルボキシメチルセルロース 0.05 0.05 0.05 精製水 残 量 残 量 残 量 *1 商品名:YOFCO CLE−NH(日本精化社製)[0030] (1) Composition Example 7 Example 8 Example 9 Ingredient a Isostearic acid 1.0 1.0 3.0 Glycerin monostearate 4.0 4.0 4.0 Behenyl alcohol 2.0 2.0 2.0 White beeswax 1.0 1.0- Cetyl myristate 1.0 1.0 1.0 Sorbitan sesquioleate 1.0 1.0 1.0 Long-chain branched fatty acid cholesteryl * 1 0.1 0.1 0.1 Hydrogenated lecithin 0.1 0.1 0.1 Plant squalane 5.0 5.0 5.0 Octyldodecyl myristate 5.0 5.0 5.0 Ingredient b Surfactin sodium 0.1 1.0 0.1 1,3-butylene glycol 5.0 10.0 0.5 Sorbitol liquid 5.0 5.0 5.0 Polyethylene glycol 4000 0.2 0.2 0.2 Carboxy vinyl polymer 0.1 0.1 0.1 Methyl paraoxybenzoate 0.2 0.2 0.2 Mevalonolactone 0.1 0.1 0.1 Disodium edetate 0.2 0.2 0.2 Raspberry ketone glucoside 0.05 0.05 0.05 Sodium chloride 0.1 0.1 0.1 Dipropylene glycol 0.1 0.1 0.1 Concentrated glycerin 5.0 5.0 5.0 Raffinose 0.1 0.1 0.1 0.1 Ascorbic acid 2-glucoside 0.1 0.1 0.1 Carboxymethyl cellulose 0.05 0.05 0.05 Purified water Residual amount Residual amount * 1 Product name: YOFCO CLE-NH (Nippon Seika)
【0031】(2)調製法
成分a及び成分bを各々80℃で溶解した後混合して、
攪拌しつつ冷却し、30℃まで冷却して、乳液を調製し
た。(2) Preparation Method Components a and b are each melted at 80 ° C. and then mixed,
The emulsion was prepared by cooling with stirring and cooling to 30 ° C.
【0032】(3)結果
実施例7〜9に係る乳液は優れた保存安定性が認められ
た。(3) Results The emulsions according to Examples 7 to 9 were found to have excellent storage stability.
【0033】実施例10〜12(美溶液)
下記の組成及び調製法に従い美容液を調製し、前記の試
験を実施した。Examples 10 to 12 (Beauty solution) A beauty essence was prepared according to the following composition and preparation method, and the above test was carried out.
【0034】 (1)組成 実施例10 実施例11 実施例12 成分a イソステアリン酸 1.0 5.0 1.0 モノステアリン酸グリセリン 4.0 4.0 4.0 ヘキシルデカノール 2.0 2.0 2.0 ニコチン酸dl−α−トコフェロール 0.1 0.1 0.1 POE(60)硬化ヒマシ油 0.2 0.2 0.2 球状シリコン粉体 *2 1.0 1.0 1.0 流動パラフィン 3.0 3.0 3.0 ホホバ油 3.0 3.0 3.0 マカデミアナッツ油脂肪酸フィトステリル 1.0 1.0 1.0 ミリスチン酸イソセチル 5.0 5.0 5.0 トリイソステアリン酸グリセリル 2.0 2.0 2.0 イソステアリン酸硬化ヒマシ油 1.0 1.0 1.0 フィトステロール 0.1 0.1 0.1 成分b サーファクチンナトリウム 1.0 1.0 0.3 1,3−ブチレングリコール 3.0 3.0 3.0 濃グリセリン 3.0 3.0 3.0 パラオキシ安息香酸メチル 0.2 0.2 0.2 N−アセチルグルコサミン 0.1 0.1 0.1 アスコルビン酸リン酸エステル マグネシウム 0.1 0.1 0.1 γ−アミノ酪酸 0.2 0.2 0.2 N−ステアロイルグルタミン酸ナトリウム 0.1 0.1 0.1 アルキル変性カルボキシビニルポリマー 0.1 0.1 0.1 ニコチン酸アミド 0.1 0.1 0.1 ザルコシン 0.1 0.1 0.1 チンピエキス 0.1 0.1 0.1 酵母エキス 0.1 0.1 0.1 甘草抽出物 0.1 0.1 0.1 N−メチル−L−セリン 0.1 0.1 0.1 精製水 残 量 残 量 残 量 *2 商品名:トスパール(東芝シリコン社製)[0034] (1) Composition Example 10 Example 11 Example 12 Ingredient a Isostearic acid 1.0 5.0 1.0 Glycerin monostearate 4.0 4.0 4.0 Hexyldecanol 2.0 2.0 2.0 Nicotinic acid dl-α-tocopherol 0.1 0.1 0.1 POE (60) hydrogenated castor oil 0.2 0.2 0.2 Spherical silicon powder * 2 1.0 1.0 1.0 Liquid paraffin 3.0 3.0 3.0 Jojoba oil 3.0 3.0 3.0 Macadamia nut oil fatty acid phytosteryl 1.0 1.0 1.0 Isocetyl myristate 5.0 5.0 5.0 Glyceryl triisostearate 2.0 2.0 2.0 Isostearic acid hydrogenated castor oil 1.0 1.0 1.0 Phytosterol 0.1 0.1 0.1 Ingredient b Surfactin sodium 1.0 1.0 0.3 1,3-butylene glycol 3.0 3.0 3.0 Concentrated glycerin 3.0 3.0 3.0 3.0 Methyl paraoxybenzoate 0.2 0.2 0.2 N-acetylglucosamine 0.1 0.1 0.1 Ascorbic acid phosphate Magnesium 0.1 0.1 0.1 γ-aminobutyric acid 0.2 0.2 0.2 Sodium N-stearoyl glutamate 0.1 0.1 0.1 Alkyl-modified carboxyvinyl polymer 0.1 0.1 0.1 Nicotinic acid amide 0.1 0.1 0.1 Sarcosine 0.1 0.1 0.1 Chinpi extract 0.1 0.1 0.1 Yeast extract 0.1 0.1 0.1 Licorice extract 0.1 0.1 0.1 N-methyl-L-serine 0.1 0.1 0.1 Purified water Residual amount Residual amount * 2 Product name: Tospearl (manufactured by Toshiba Silicon)
【0035】成分a及び成分bを各々80℃で溶解した
後混合して、攪拌しつつ冷却し、30℃まで冷却して、
美容液を調製した。The components a and b were each melted at 80 ° C., then mixed, cooled with stirring and cooled to 30 ° C.,
A beauty essence was prepared.
【0036】(3)結果
実施例10〜12に係る美容液は優れた保存安定性が認
められた。(3) Results The beauty essences of Examples 10 to 12 were confirmed to have excellent storage stability.
【0037】尚、いずれの実施例の乳化型皮膚外用剤を
使用した場合にも、皮膚に発赤、炎症、その他副作用と
考えられる症状は発現せず、本発明に係る乳化型皮膚外
用剤は安全性にも優れることが明らかであった。When any of the emulsified external preparations for skin of the present invention is used, no redness, inflammation, or other side effects are observed on the skin, and the external preparation for emulsified skin according to the present invention is safe. It was clear that it was also excellent in sex.
【0038】[0038]
【発明の効果】以上のごとく、本発明が、グリセリンモ
ノ脂肪酸エステルを多量に含みながら幅広い粘度領域を
持ち、且つ保存安定性に優れた乳液状皮膚外用剤を提供
することは明らかである。INDUSTRIAL APPLICABILITY As described above, it is apparent that the present invention provides a milky liquid external preparation for skin which has a wide viscosity range while containing a large amount of glycerin monofatty acid ester and is excellent in storage stability.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61K 9/10 A61K 9/10 47/12 47/12 47/14 47/14 47/42 47/42 (72)発明者 小林 悦子 神奈川県小田原市寿町5丁目3番28号 カ ネボウ株式会社化粧品研究所内 Fターム(参考) 4C076 AA16 BB31 DD41A DD46A EE41A FF11 FF16 4C083 AA082 AA112 AA122 AB172 AC062 AC122 AC132 AC241 AC242 AC312 AC352 AC391 AC392 AC432 AC442 AC482 AC522 AC582 AC622 AD042 AD092 AD392 AD411 AD412 AD472 AD642 AD662 CC03 CC05 DD31 EE01 EE11 ─────────────────────────────────────────────────── ─── Continuation of front page (51) Int.Cl. 7 Identification code FI theme code (reference) A61K 9/10 A61K 9/10 47/12 47/12 47/14 47/14 47/42 47/42 ( 72) Inventor Etsuko Kobayashi 5-328, Kotobukicho, Odawara-shi, Kanagawa F-Term in Kanebo Co., Ltd. Cosmetic Research Center (reference) AC391 AC392 AC432 AC442 AC482 AC522 AC582 AC622 AD042 AD092 AD392 AD411 AD412 AD472 AD642 AD662 CC03 CC05 DD31 EE01 EE11
Claims (2)
(B)微生物由来のリポペプチド類、及び(C)25℃
で液状の高級脂肪酸を含有することを特徴とする乳化型
皮膚外用剤。1. (A) Glycerin monofatty acid ester,
(B) Microorganism-derived lipopeptides, and (C) 25 ° C.
An emulsion type external preparation for skin, characterized in that it contains a liquid higher fatty acid.
脂肪酸であることを特徴とする請求項1記載の乳化型皮
膚外用剤。2. The emulsion-type external preparation for skin according to claim 1, wherein (C) the higher fatty acid liquid at 25 ° C. is a branched fatty acid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002085075A JP2003277220A (en) | 2002-03-26 | 2002-03-26 | External preparation for skin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002085075A JP2003277220A (en) | 2002-03-26 | 2002-03-26 | External preparation for skin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2003277220A true JP2003277220A (en) | 2003-10-02 |
Family
ID=29232169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002085075A Pending JP2003277220A (en) | 2002-03-26 | 2002-03-26 | External preparation for skin |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2003277220A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005020950A1 (en) * | 2003-08-28 | 2005-03-10 | Showa Denko K.K. | Cosmetic composition comprising a and a lipopeptide |
| JP2011219383A (en) * | 2010-04-06 | 2011-11-04 | Noevir Co Ltd | External preparation for skin |
| JP2017500322A (en) * | 2013-12-24 | 2017-01-05 | ザ プロクター アンド ギャンブル カンパニー | Cosmetic composition and method for providing high permeability of skin care active ingredients |
| CN107184541A (en) * | 2017-05-19 | 2017-09-22 | 广州蜜妆生物科技有限公司 | A kind of composite natral low energy consumption emulsification composition |
| US10549129B2 (en) | 2016-06-24 | 2020-02-04 | The Procter & Gamble Company | Cosmetic compositions and methods providing enhanced penetration of skin care actives |
| EP4076350A1 (en) * | 2019-12-20 | 2022-10-26 | L V M H Recherche | Oil-in-water emulsified cosmetic |
| WO2024140894A1 (en) | 2022-12-30 | 2024-07-04 | 株式会社资生堂 | Cosmetic composition |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5824325A (en) * | 1981-08-05 | 1983-02-14 | Shiseido Co Ltd | Oil-in-water type emulsified composition |
| JPS5978149A (en) * | 1982-09-22 | 1984-05-04 | セントル・ナシヨナル・ドウ・ラ・ルシエルシエ・シヤンテイフイツク | Lipopeptides, manufacture and use as emulsifier |
| JPS63305930A (en) * | 1987-06-05 | 1988-12-13 | Kobayashi Kooc:Kk | Emulsion composition |
| JP2000327591A (en) * | 1998-05-29 | 2000-11-28 | Showa Denko Kk | Surfactant for skin preparation for external use and skin preparation for external use containing the same |
| JP2001002551A (en) * | 1999-06-18 | 2001-01-09 | Kanebo Ltd | Agent for increasing hyaluronic acid content of horny layer |
| JP2001151660A (en) * | 1999-11-24 | 2001-06-05 | Shiseido Co Ltd | Skin preparation for external use |
| JP2001206835A (en) * | 2000-01-25 | 2001-07-31 | Kanebo Ltd | Collagen synthesis promoter and collagen metabolism activator |
-
2002
- 2002-03-26 JP JP2002085075A patent/JP2003277220A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5824325A (en) * | 1981-08-05 | 1983-02-14 | Shiseido Co Ltd | Oil-in-water type emulsified composition |
| JPS5978149A (en) * | 1982-09-22 | 1984-05-04 | セントル・ナシヨナル・ドウ・ラ・ルシエルシエ・シヤンテイフイツク | Lipopeptides, manufacture and use as emulsifier |
| JPS63305930A (en) * | 1987-06-05 | 1988-12-13 | Kobayashi Kooc:Kk | Emulsion composition |
| JP2000327591A (en) * | 1998-05-29 | 2000-11-28 | Showa Denko Kk | Surfactant for skin preparation for external use and skin preparation for external use containing the same |
| JP2001002551A (en) * | 1999-06-18 | 2001-01-09 | Kanebo Ltd | Agent for increasing hyaluronic acid content of horny layer |
| JP2001151660A (en) * | 1999-11-24 | 2001-06-05 | Shiseido Co Ltd | Skin preparation for external use |
| JP2001206835A (en) * | 2000-01-25 | 2001-07-31 | Kanebo Ltd | Collagen synthesis promoter and collagen metabolism activator |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005020950A1 (en) * | 2003-08-28 | 2005-03-10 | Showa Denko K.K. | Cosmetic composition comprising a and a lipopeptide |
| JP2011219383A (en) * | 2010-04-06 | 2011-11-04 | Noevir Co Ltd | External preparation for skin |
| JP2017500322A (en) * | 2013-12-24 | 2017-01-05 | ザ プロクター アンド ギャンブル カンパニー | Cosmetic composition and method for providing high permeability of skin care active ingredients |
| US10549129B2 (en) | 2016-06-24 | 2020-02-04 | The Procter & Gamble Company | Cosmetic compositions and methods providing enhanced penetration of skin care actives |
| CN107184541A (en) * | 2017-05-19 | 2017-09-22 | 广州蜜妆生物科技有限公司 | A kind of composite natral low energy consumption emulsification composition |
| EP4076350A1 (en) * | 2019-12-20 | 2022-10-26 | L V M H Recherche | Oil-in-water emulsified cosmetic |
| WO2024140894A1 (en) | 2022-12-30 | 2024-07-04 | 株式会社资生堂 | Cosmetic composition |
| EP4643845A1 (en) | 2022-12-30 | 2025-11-05 | Shiseido Company, Ltd. | Cosmetic composition |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3142245B2 (en) | External preparation for skin | |
| TWI395596B (en) | Emulsion composition | |
| CN101772340B (en) | Liquid cosmetic preparation | |
| JP5432470B2 (en) | Ceramide solution and external preparation for skin | |
| JP4812232B2 (en) | Emulsified composition | |
| WO2007148474A1 (en) | Preparation for external application to skin containing triterpenic acid | |
| JP2012017318A (en) | Liquid crystal and skin external preparation containing the same | |
| JP2003176211A (en) | Oily thickened gel-like composition, emulsified composition using the same and method for preparing the emulsified composition | |
| JP2002068957A (en) | Emulsion-type skin care preparation | |
| JP4989119B2 (en) | Skin external preparation suitable for vesicle system | |
| JP5069965B2 (en) | Topical skin preparation | |
| JP2005179313A (en) | Method for producing base agent for skin cosmetic, and skin cosmetic | |
| JP2005187465A (en) | Emulsified skin care preparation for external use containing salt of higher fatty acid ester of ascorbic acid-2-phosphoric acid ester, method for producing the same, and method for stabilizing the salt of ester | |
| JP5165299B2 (en) | Topical skin preparation | |
| JP2003277220A (en) | External preparation for skin | |
| JP2001261568A (en) | Production accelerator of profilaggrin and/or filaggrin protein | |
| JP4672328B2 (en) | Skin external preparation containing ascorbic acid derivative salt, method for stabilizing skin external preparation, and stabilizer | |
| JP2003277250A (en) | Skin care preparation | |
| JP3645213B2 (en) | Topical skin preparation | |
| JP2005089427A (en) | Skin care preparation for external use | |
| JP2003267830A (en) | Liquid cosmetic | |
| JP3441387B2 (en) | Moisturizer, skin cosmetics and bath additives | |
| JP2003212750A (en) | Gel composition and emulsified composition | |
| JP2005187466A (en) | Skin care preparation for external use containing salt of higher fatty acid ester of ascorbic acid-2-phosphoric acid ester, method for stabilizing the salt of ester, and stabilizing agent | |
| KR20230150260A (en) | liposome composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20040806 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20040806 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20041105 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20050614 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050719 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050920 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20060110 |